Patents Represented by Attorney David Chang
  • Patent number: 8153390
    Abstract: The present invention provides for an assay that identifies kinase inhibitors by employing fluorescence resonance energy transfer in a competition binding approach.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: April 10, 2012
    Assignee: Roche Palo Alto LLC
    Inventors: James Michael Bradshaw, Joyce Karen Kwan, Alden Er Hong Ling, David Shaw